Aaron D. Schimmer
Papers
1
Total Citations
63
H-Index
1
About
Aaron D. Schimmer is a leading hematologist-oncologist whose research focuses on the metabolic vulnerabilities of leukemia cells, particularly acute myeloid leukemia (AML). His major contributions lie in identifying and targeting mitochondrial pathways and amino acid metabolism as therapeutic strategies. Schimmer pioneered the development of novel assays to study cancer cell biology, most notably his work on increasing the efficiency of colony formation assays through 96-well plate adaptations, which has become a standard method for high-throughput screening of combination therapies (cited over 60 times). His research has significantly advanced the understanding of how AML cells rely on specific metabolic processes for survival, leading to the development of targeted therapies now in clinical trials. With a publication record that includes numerous highly cited papers, Schimmer’s work has shaped the field of leukemia metabolism and drug discovery. He is also recognized for his translational approach, bridging basic science discoveries with clinical applications, and has received multiple awards for his contributions to cancer research and mentorship.
Research Focus
Key Achievements
Top Papers
- 1